LivaNova appoints Brooke Story to Board of Directors effective Sept 15, 2022

LivaNova PLC

Brooke Story appointed to LivaNova Board, brings over 20 years in medtech; currently Worldwide President at BD.
Story previously held leadership roles at Medtronic, including President of Pelvic Health and Gastric Therapies.
She will receive a prorated annual board retainer of $110,000, NG committee fee of $8,000, and $130,000 RSU grant.
No arrangement or related-party transactions exist between Story and LivaNova.
Story fills a board vacancy; compensation consistent with company's Remuneration Policy for non-employee directors.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brooke Story

Director

LIVN · LivaNova PLC

Effective: 2022-09-15
Filed: September 15, 2022, 7:59 PM ET

On September 15, 2022, the Board of Directors (the “Board”) of LivaNova PLC (the “Company” or “LivaNova”) appointed Brooke Story to the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brooke Story was appointed as Director at LivaNova PLC.

Action: appointed
Role: Director

Exact text from the filing

On September 15, 2022, the Board of Directors (the “Board”) of LivaNova PLC (the “Company” or “LivaNova”) appointed Brooke Story to the Board.

View on SEC.gov

LivaNova PLC filing history →

Source: SEC EDGAR

accession 0001639691-22-000088

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.